ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Dichloromethane → N-(3-(3-(cyclopropanecarboxamido)isoquinolin-7-yl)-4-methylphenyl)-2-(hydroxymethyl)morpholine-4-carboxamide

HRID 468735
印刷

反応式

HRID 468735 の反応式
Cl[C:2](Cl)([O:4]C(=O)OC(Cl)(Cl)Cl)Cl.C(N(CC)C(C)C)(C)C.C(Cl)Cl.[NH2:25][C:26]1[CH:27]=[CH:28][C:29]([CH3:48])=[C:30]([C:32]2[CH:41]=[C:40]3[C:35]([CH:36]=[C:37]([NH:42][C:43]([CH:45]4[CH2:47][CH2:46]4)=[O:44])[N:38]=[CH:39]3)=[CH:34][CH:33]=2)[CH:31]=1.[NH:49]1[CH2:54][CH2:53][O:52][CH:51]([CH2:55][OH:56])[CH2:50]1>>[CH:45]1([C:43]([NH:42][C:37]2[N:38]=[CH:39][C:40]3[C:35]([CH:36]=2)=[CH:34][CH:33]=[C:32]([C:30]2[CH:31]=[C:26]([NH:25][C:2]([N:49]4[CH2:54][CH2:53][O:52][CH:51]([CH2:55][OH:56])[CH2:50]4)=[O:4])[CH:27]=[CH:28][C:29]=2[CH3:48])[CH:41]=3)=[O:44])[CH2:46][CH2:47]1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 5

HCID 6344Dichloromethane2 回HCID 81531Diisopropylethylamine2 回HCID 94429TriphosgeneHCID 3497988Morpholin-2-ylmethanolHCID 67974803N-(7-(5-amino-2-methylphenyl)isoquinolin-3-yl)cyclopropanecarboxamide

生成物 1

HCID 57411212
N-(3-(3-(cyclopropanecarboxamido)isoquinolin-7-yl)-4-methylphenyl)-2-(hydroxymethyl)morpholine-4-carboxamide
収率 98.2%

実験手順

To a solution of triphosgene (22.7 mg, 0.0765 mmol) and N,N-diisopropylethylamine (0.20 mL, 1.1 mmol) in methylene chloride (4.0 mL, 62 mmol) was added a solution of N-(7-(5-amino-2-methylphenyl)isoquinolin-3-yl)cyclopropanecarboxamide (59.9 mg, 0.189 mmol) and N,N-diisopropylethylamine (0.10 mL, 0.57 mmol) in methylene chloride (2.0 mL, 31 mmol). The resulting mixture was stirred at room temperature for 5 minutes, and then morpholin-2-ylmethanol (37.5 mg, 0.320 mmol) was added. The reaction mixture was stirred at room temperature for an additional 30 minutes, and then filtered through silica which was rinsed with ethyl acetate, and evaporated in vacuo. The crude product was purified via reverse phase HPLC and lyophilized to yield 34.6 mg (40%) of N-(3-(3-(cyclopropanecarboxamido)isoquinolin-7-yl)-4-methylphenyl)-2-(hydroxymethyl)morpholine-4-carboxamide. LCMS (ESI): RT (min)=3.964, M+H=461.2, method=E; 1H NMR (400 MHz, DMSO-d6) δ 10.87 (s, 1H), 9.18 (s, 1H), 8.56 (s, 1H), 8.47 (s, 1H), 7.98 (s, 1H), 7.91 (d, J=8.5 Hz, 1H), 7.68 (d, J=8.5 Hz, 1H), 7.50-7.37 (m, 2H), 7.21 (d, J=8.2 Hz, 1H), 4.82 (t, J=5.5 Hz, 1H), 4.04 (d, J=12.9 Hz, 2H), 3.97-3.81 (m, 3H), 2.90 (t, J=6.0 Hz, 2H), 2.64 (dd, J=12.9, 10.0 Hz, 2H), 2.21 (s, 3H), 2.11-2.03 (m, 1H), 0.86 (m, 4H).

後処理

  1. stirringThe reaction mixture was stirred at room temperature for an additional 30 minutes
  2. filtrationfiltered through silica which
  3. washwas rinsed with ethyl acetate
  4. customevaporated in vacuo
  5. customThe crude product was purified via reverse phase HPLC

出典と根拠

ORDレコード
ord-14a57a11b98040a2a4262275e4b09114
出典データセット
uspto-grants-2014_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08623889B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート